I. Batsis

发表

Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single‐center study

E. Yannaki, A. Anagnostopoulos, I. Sakellari, 2018, Journal of clinical apheresis.

Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: a study by the Hellenic association of hematology.

S. Papageorgiou, A. Anagnostopoulos, I. Sakellari, 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Carmustine, etoposide, cytarabine and melphalan versus a newly designed intravenous busulfan-based Busulfex, etoposide and melphalan conditioning regimen for autologous hematopoietic cell transplant: a retrospective matched-pair analysis in advanced Hodgkin and non-Hodgkin lymphomas

E. Yannaki, A. Anagnostopoulos, I. Sakellari, 2015, Leukemia & lymphoma.

Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and nonsplenectomized subjects.

G. Stamatoyannopoulos, A. Xagorari, T. Papayannopoulou, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Predictors of Transplant-Associated Thrombotic Microangiopathy in Patients With Overlap or Chronic Graft-vs-Host-Disease.

T. Chatzikonstantinou, E. Yannaki, A. Anagnostopoulos, 2021, Transplantation proceedings.

Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation

T. Chatzikonstantinou, E. Yannaki, A. Anagnostopoulos, 2020, HemaSphere.

Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease

A. Anagnostopoulos, A. Ilias, I. Sakellari, 2019, International Journal of Hematology.

Transplant‐associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation

E. Yannaki, A. Anagnostopoulos, I. Sakellari, 2018, Clinical transplantation.

Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long‐Term Engraftment and No Ectopic Tissue Formation

O. Ringdén, K. Le Blanc, Guido Moll, 2012, Stem cells.

Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis

G. Vassilopoulos, K. Konstantopoulos, M. Angelopoulou, 2018, Hematological oncology.

A. Anagnostopoulos, A. Fassas, A. Athanasiadou, 2002, Leukemia & lymphoma.

Candida is an emerging pathogen beyond the neutropenic period of allogeneic hematopoietic cell transplantation

E. Yannaki, A. Anagnostopoulos, I. Sakellari, 2017, Clinical transplantation.

Brentuximab vedotin and anti‐PD1 treatment optimize survival in chemo‐refractory Hodgkin lymphoma patients: Real‐world data

A. Anagnostopoulos, N. Stavroyianni, I. Sakellari, 2019, Hematological Oncology.

Adolescents and young adults (AYA) with acute myeloid leukemia (AML): real-world long-term results and age-specific outcomes

M. Papathanasiou, A. Athanasiadou, C. Demosthenous, 2022, Leukemia & lymphoma.

Secondary Acute Myeloid Leukemia (sAML): Similarly Dismal Outcomes of AML After an Antecedent Hematologic Disorder and Therapy Related AML.

M. Papathanasiou, A. Anagnostopoulos, A. Athanasiadou, 2021, Clinical lymphoma, myeloma & leukemia.

Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation

T. Chatzikonstantinou, A. Anagnostopoulos, Stergios Papadimitriou, 2019, Frontiers in Medicine.

The Role of Low‐dose Anti‐thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies

E. Yannaki, A. Anagnostopoulos, N. Stavroyianni, 2017, Clinical lymphoma, myeloma & leukemia.

Veno-occlusive disease prophylaxis with fresh frozen plasma and heparin in bone marrow transplantation.

I. Georgoulis, E. Yannaki, A. Anagnostopoulos, 2006, Thrombosis research.

Linking Complement Activation, Coagulation, and Neutrophils in Transplant-Associated Thrombotic Microangiopathy

R. Brodsky, A. Anagnostopoulos, I. Mitroulis, 2019, Thrombosis and Haemostasis.

Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis

E. Yannaki, A. Anagnostopoulos, A. Fassas, 2012, Annals of the rheumatic diseases.

Tissue-Specific Progenitor and Stem Cells Type 1 Diabetes Mellitus Donor Mesenchymal Stromal Cells Exhibit Comparable Potency to Healthy Controls In Vitro

H. Qian, B. Nilsson, K. Salmela, 2016 .

Development of Classic Hodgkin Lymphoma after successful treatment of primary mediastinal large b-cell lymphoma: results from a well-defined database.

M. Dimopoulos, M. Angelopoulou, G. Pangalis, 2020, Leukemia research.

Assessment of Endothelial Injury and Pro-Coagulant Activity Using Circulating Microvesicles in Survivors of Allogeneic Hematopoietic Cell Transplantation

P. Anyfanti, S. Douma, A. Anagnostopoulos, 2020, International journal of molecular sciences.

Mobilization of hematopoietic stem cells in a thalassemic mouse model: implications for human gene therapy of thalassemia.

E. Yannaki, A. Anagnostopoulos, M. Arsenakis, 2010, Human gene therapy.

Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes

A. Anagnostopoulos, A. Athanasiadou, I. Sakellari, 2014, Bone Marrow Transplantation.

Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity

V. Papadopoulos, E. Yannaki, A. Anagnostopoulos, 2021, EJHaem.

Aplastic anemia and paroxysmal nocturnal hemoglobinuria in children and adults in two centers of Northern Greece

M. Papathanasiou, A. Tragiannidis, A. Athanasiadou, 2022, Frontiers in Oncology.

GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation

A. Barbouti, E. Yannaki, I. Sakellari, 2013, Bone Marrow Transplantation.

Isolated Extramedullary Relapse as a Poor Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia.

E. Yannaki, A. Anagnostopoulos, I. Sakellari, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transfer.

M. Papathanasiou, E. Yannaki, A. Anagnostopoulos, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality

D. Kazis, E. Yannaki, A. Anagnostopoulos, 2019, Journal of Neurology.

Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath?

K. Stamatopoulos, D. Margaritis, I. Kotsianidis, 2019, Leukemia & lymphoma.

Transient monoclonal CD3+ T large granular lymphocyte proliferation in a case of mantle cell lymphoma with Rituximab‐associated late onset neutropenia

K. Stamatopoulos, A. Anagnostopoulos, E. Stalika, 2011, Hematological oncology.

Molecular evidence for repertoire skewing of T large granular lymphocyte proliferation after allogeneic hematopoietic SCT: report of two cases

K. Stamatopoulos, A. Anagnostopoulos, M. Karypidou, 2013, Bone Marrow Transplantation.

Pretransplant Genetic Susceptibility: Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy

K. Stamatopoulos, R. Brodsky, M. Tsagiopoulou, 2020, Thrombosis and Haemostasis.

Unraveling the Genetics of Transplant-Associated Thrombotic Microangiopathy: Lessons to be Learned.

E. Yannaki, A. Anagnostopoulos, I. Sakellari, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Easix Is Strongly Associated with Complement Activation and Overall Survival in Adult Allogeneic Hematopoietic Cell Transplantation Recipients

E. Yannaki, A. Anagnostopoulos, A. Athanasiadou, 2019, Blood.

The 45th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians – Poster Session

Evangelia, Marianna, É., 2019, Bone Marrow Transplantation.

Transplant‐associated thrombotic microangiopathy: an unresolved complication of unrelated allogeneic transplant for hematologic diseases

Achilles Anagnostopoulos, E. Yannaki, A. Anagnostopoulos, 2017, Hematological oncology.

Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change

A. Anagnostopoulos, I. Sakellari, E. Gavriilaki, 2020, HemaSphere.

Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study

M. Papathanasiou, E. Yannaki, A. Anagnostopoulos, 2018, Annals of Hematology.

Silent T‐cell lymphoma of γδ T‐cell origin initially presented as panniculitis

D. Sotiriadis, T. Papadaki, I. Sakellari, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs.

A. Xagorari, E. Yannaki, A. Anagnostopoulos, 2005, Experimental hematology.

Survival advantage of treosulfan plus fludarabine before allogeneic hematopoietic cell transplantation for older or comorbid patients with myeloid malignancies.

M. Papathanasiou, K. Antoniadis, A. Anagnostopoulos, 2021, Transplantation and cellular therapy.

Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Cell Transplantation.

E. Yannaki, A. Anagnostopoulos, A. Athanasiadou, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Derivative (1;7)(q10;p10) in two patients with myelodysplastic syndrome after autologous haematopoietic cell transplantation

A. Anagnostopoulos, A. Athanasiadou, I. Batsis, 2011, Hematological oncology.

Case study of betibeglogene autotemcel gene therapy in an adult Greek patient with transfusion‐dependent β‐thalassaemia of a severe genotype

Despoina Papadopoulou, E. Yannaki, A. Anagnostopoulos, 2021, British journal of haematology.

Sequential transient novel chromosomal translocations in a patient with chronic myelogenous leukemia in complete cytogenetic remission after therapy with imatinib mesylate.

A. Anagnostopoulos, A. Athanasiadou, I. Batsis, 2011, Cancer Genetics.

Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia

K. Stamatopoulos, G. Paterakis, H. Papadaki, 2008, Leukemia.

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience

M. Angelopoulou, G. Pangalis, M. Kyrtsonis, 2017, Hematological oncology.

A non-interventional study of microcirculation dynamics in allogeneic hematopoietic cell transplantation survivors compared to controls: evidence of impaired microvascular response regardless of conventional cardiovascular risk factors

P. Anyfanti, S. Douma, A. Anagnostopoulos, 2021, Bone Marrow Transplantation.

BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma

A. Anagnostopoulos, I. Sakellari, E. Gavriilaki, 2018, Bone Marrow Transplantation.

Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells.

A. Xagorari, E. Yannaki, A. Anagnostopoulos, 2006, Experimental hematology.

Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor

I. Lazana, I. Sakellari, E. Gavriilaki, 2023, International journal of molecular sciences.

Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients

G. Karavalakis, M. Giannaki, E. Yannaki, 2022, Bone Marrow Transplantation.

Risk Factors, Prevalence, and Outcomes of Invasive Fungal Disease Post Hematopoietic Cell Transplantation and Cellular Therapies: A Retrospective Monocenter Real-Life Analysis

E. Yannaki, A. Anagnostopoulos, C. Demosthenous, 2023, Cancers.

Autologous HSCT for systemic sclerosis

A. Anagnostopoulos, I. Sakellari, E. Gavriilaki, 2013, The Lancet.

Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World Experience

A. Anagnostopoulos, C. Demosthenous, I. Sakellari, 2023, Cancers.

E. Yannaki, A. Anagnostopoulos, I. Sakellari, 2015, Leukemia & lymphoma.

Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes

E. Yannaki, A. Anagnostopoulos, C. Demosthenous, 2023, International journal of molecular sciences.

Open-Label Randomized Controlled Study of Ciprofloxacin vs Rifaximin as Neutropenia Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation.

A. Anagnostopoulos, C. Demosthenous, I. Sakellari, 2024, Transplantation proceedings.

low body mass index is an independent risk factor for transplant-associated microangiopathy following total-body irradiation-based conditioning regimens.

E. Yannaki, I. Sakellari, I. Batsis, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients

E. Yannaki, I. Sakellari, I. Batsis, 2023, International journal of molecular sciences.